[Skip to Content]
[Skip to Content Landing]
March 23 2011

Clinical Trial Enrollment and Progress in Women’s Health

JAMA. 2011;305(12):1197-1198. doi:10.1001/jama.2011.347

To the Editor: Dr Adler recently commented on the Institute of Medicine recommendations to help foster progress in women's health by increasing the availability of sex-specific data.1 We believe that the best way to guarantee that adequate sex-specific data are acquired and examined is if insurers require such data for coverage of drugs, devices, or other medical interventions. The Centers for Medicare & Medicaid Services (CMS) should lead the way, both because its funding comes from taxpayers and because many insurers follow their coverage decisions.